CUTANEOUS melanoma has become a common form of cancer. 1 Decades of steady
increases in the incidence and mortality rates of cutaneous malignant melanoma have …

Skin cancer (SC) poses a global threat to the healthcare system and is expected to increase
significantly over the next two decades if not diagnosed at an early stage. Early diagnosis is …

Background Zyflamend, a mixture containing extracts of ten herbs, has shown promise in a
variety of preclinical cancer models, including prostate cancer. The current experiments …

Background Zyflamend, a blend of herbal extracts, effectively inhibits tumor growth using
preclinical models of castrate-resistant prostate cancer mediated in part by 5′-adenosine …

Zyflamend is a highly controlled blend of 10 herbal extracts that synergistically impact
multiple cell signaling pathways with anticancer and anti-inflammatory properties. More …

A select blend of herbal extracts, Zyflamend, inhibits tumour growth via multiple mechanisms
that arise through synergistic interactions between individual components. The objective in …

Cancer is a multifaceted disease. Our deepened knowledge about genetic and biological
mechanisms of cancer cells presents an opportunity to explore the inter-individual …

Background Cisplatin-based chemotherapy is mainstay treatment in urinary bladder cancer
(UBC). However, tumor recurrence frequently occurs with the acquisition of cisplatin …

Background Current pharmacological therapies and treatments targeting pancreatic
neuroendocrine tumors (PNETs) have proven ineffective, far too often. Therefore, there is an …

Isoamylamine (IA) is an aliphatic monoamine molecule present in cheese, eggs, and wine. It
belongs to the family of polyamines and also can be synthesized endogenously. It has been …